The Innovation Bridge concentrates on the vaccine priorities of the Bill & Melinda Gates Foundation, including vaccines against:
| Vaccine Area | Number in Development |
|---|---|
| Diarrheal Diseases | 43 |
| HIV/AIDS | 56 |
| Malaria | 29 |
| Tuberculosis | 18 |
| Pneumonia-Related Diseases | 17 |
| Total | 163 |
Each of the five target areas above includes a list of vaccines in development, the vaccine developer or academic/university/government group conducting research and developing the vaccine, and the current known phase of development. The complete list of vaccines in development and the accompanying information in the five target areas will be updated regularly (at least every three months, if not more frequently), so check back routinely for new information.
Vaccine developers and academic/university/government groups: please contact the Innovation Bridge team (innovationbridge@med.umich.edu) to update or otherwise correct information for your vaccine(s) in development.
